Intermittent Subcutaneous Furosemide: Parenteral Diuretic Rescue for Hospice Patients With Congestive Heart Failure Resistant to Oral Diuretic

American Journal of Hospice and Palliative Medicine

Volumn 30, Issue 8, 2013, Pages 791-792

  Farless, Laura B ^a   Steil, Neal ^a   Williams, Beverly Rosa ^a   Bailey, F Amos ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

congestive heart failure; diuretic resistance; dyspnea; home infusion; hospice; subcutaneous therapy

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

HEART FAILURE; HOSPICE; HOSPICE CARE; HUMAN;

DIURETICS; FUROSEMIDE; HEART FAILURE; HOSPICE CARE; HOSPICES; HUMANS;

EID: 84888268893     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909112465795     Document Type: Article

References (5)

1. Goldfinger JZ,Adler ED.End-of-life options for patients with advanced heart failure.Curr Heart Fail Rep. 2010;7 (3): 140-147.
2. Zacharias H,Raw J,Nunn A,Parsons S,Johnson M.Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?.Palliat Med. 2011;25 (6): 658-663.
3. Verma Arun K,da Silva JH,Kuhl DR.Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.Ann Pharmacother. 2004;38 (4): 544-549.
4. Herdon CM,Fike DS.Continuous subcutaneous infusion practices of United States hospices.J Pain Symptom Manage. 2001;22 (6): 1027-1034.
5. Fonzo-Christe C,Vukasovic C,Wasilewski-Rasca AF,Bonnabry P.Subcutaneous administration of drugs in the elderly: survey of practice and systematic review.Palliat Med. 2005;19 (3): 208-219.